COS certificate should be essential for effective entry into European market
Published: 2002-11-13 07:00:00
Updated: 2002-11-13 07:00:00
The successful entry of the domestic pharmaceutical firms into the European market requires the acquisition of COS (Certification of Suitability of Monographs of the European Pharmacopoeia), according to the Korea Pharmaceutical Traders Association (KPTA) and related industry.
The KPTA said th...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
